New Developments of Clinical Trial in Immunotherapy for Alzheimer's Disease

Publisher： Bentham Science Publishers

E-ISSN： 1873-4316|16|6|484-491

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.16, Iss.6, 2015-01, pp. : 484-491

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A phase II trial of the new immunotherapy agent, Alzheimer's disease vaccine [AN-1792],

By  

Inpharma, Vol. 1, Iss. 1326, 2002-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite

An Overview of Immunotherapy for Allergic Disease: New Developments and Future Strategies

By  

Medicinal Chemistry Reviews - Online, Vol. 1, Iss. 2, 2004-04 ,pp. : 163-177

Bentham Science Publishers

Access to resources Recommend Favorite

Current status and new developments with galantamine in the treatment of Alzheimer’s disease

By Tariot Pierre  

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 12, 2001-12 ,pp. : 2027-2049

Informa Healthcare

Access to resources Recommend Favorite

Immunotherapy in a Rabbit Model of Alzheimer’s Disease

By S. Woodruff-Pak Diana   Shriver Christina   Agelan Alexis   M. Manns Joanne   Coico Richard  

Drug Delivery Letters, Vol. 2, Iss. 1, 2012-03 ,pp. : 14-21

Bentham Science Publishers

Access to resources Recommend Favorite

Validating Immunotherapy in Alzheimer’s Disease: The EB101 Vaccine

By  

Current Pharmaceutical Design, Vol. 22, Iss. 7, 2016-02 ,pp. : 849-858

Bentham Science Publishers

Access to resources Recommend Favorite